|
1
|
Neurath MF and Finotto S: The many roads
to inflammatory bowel diseases. Immunity. 25:189–191. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Strober W, Fuss I and Mannon P: The
fundamental basis of inflammatory bowel disease. J Clin Invest.
117:514–521. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vermeire S, Ferrante M and Rutgeerts P:
Recent advances: Personalised use of current Crohn's disease
therapeutic options. Gut. 62:1511–1515. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kono T, Kanematsu T and Kitajima M: Exodus
of Kampo, traditional Japanese medicine, from the complementary and
alternative medicines: Is it time yet? Surgery. 146:837–840. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Endo S, Nishida T, Nishikawa K, Nakajima
K, Hasegawa J, Kitagawa T, Ito T and Matsuda H: Dai-kenchu-to, a
Chinese herbal medicine, improves stasis of patients with total
gastrectomy and jejunal pouch interposition. Am J Surg. 192:9–13.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Itoh T, Yamakawa J, Mai M, Yamaguchi N and
Kanda T: The effect of the herbal medicine dai-kenchu-to on
post-operative ileus. J Int Med Res. 30:428–432. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Iwai N, Kume Y, Kimura O, Ono S, Aoi S and
Tsuda T: Effects of herbal medicine Dai-Kenchu-to on anorectal
function in children with severe constipation. Eur J Pediatr Surg.
17:115–118. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Suehiro T, Matsumata T, Shikada Y and
Sugimachi K: The effect of the herbal medicines dai-kenchu-to and
keishi-bukuryo-gan on bowel movement after colorectal surgery.
Hepatogastroenterology. 52:97–100. 2005.PubMed/NCBI
|
|
9
|
Tokita Y, Satoh K, Sakaguchi M, Endoh Y,
Mori I, Yuzurihara M, Sakakibara I, Kase Y, Takeda S and Sasaki H:
The preventive effect of Daikenchuto on postoperative
adhesion-induced intestinal obstruction in rats.
Inflammopharmacology. 15:65–66. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Murata P, Kase Y, Ishige A, Sasaki H,
Kurosawa S and Nakamura T: The herbal medicine Dai-kenchu-to and
one of its active components [6]-shogaol increase intestinal blood
flow in rats. Life Sci. 70:2061–2070. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kono T, Koseki T, Chiba S, Ebisawa Y,
Chisato N, Iwamoto J and Kasai S: Colonic vascular conductance
increased by Daikenchuto via calcitonin gene-related peptide and
receptor-activity modifying protein 1. J Surg Res. 150:78–84. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kono T, Kaneko A, Hira Y, Suzuki T,
Chisato N, Ohtake N, Miura N and Watanabe T: Anti-colitis and
-adhesion effects of daikenchuto via endogenous adrenomedullin
enhancement in Crohn's disease mouse model. J Crohns Colitis.
4:161–170. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Eto T: A review of the biological
properties and clinical implications of adrenomedullin and
proadrenomedullin N-terminal 20 peptide (PAMP), hypotensive and
vasodilating peptides. Peptides. 22:1693–1711. 2001. View Article : Google Scholar
|
|
14
|
Julián M, Cacho M, García MA,
Martín-Santamaría S, de Pascual-Teresa B, Ramos A, Martínez A and
Cuttitta F: Adrenomedullin: A new target for the design of small
molecule modulators with promising pharmacological activities. Eur
J Med Chem. 40:737–750. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Marutsuka K, Nawa Y, Asada Y, Hara S,
Kitamura K, Eto T and Sumiyoshi A: Adrenomedullin and
proadrenomudullin N-terminal 20 peptide (PAMP) are present in human
colonic epithelia and exert an antimicrobial effect. Exp Physiol.
86:543–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gonzalez-Rey E, Fernandez-Martin A, Chorny
A and Delgado M: Therapeutic effect of urocortin and adrenomedullin
in a murine model of Crohn's disease. Gut. 55:824–832. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Talero E, Sánchez-Fidalgo S, de la Lastra
CA, Illanes M, Calvo JR and Motilva V: Acute and chronic responses
associated with adrenomedullin administration in experimental
colitis. Peptides. 29:2001–2012. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ashizuka S, Ishikawa N, Kato J, Yamaga J,
Inatsu H, Eto T and Kitamura K: Effect of adrenomedullin
administration on acetic acid-induced colitis in rats. Peptides.
26:2610–2615. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gonzalez-Rey E, Chorny A, O'Valle F and
Delgado M: Adrenomedullin protects from experimental arthritis by
down-regulating inflammation and Th1 response and inducing
regulatory T cells. Am J Pathol. 170:263–271. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kono T, Omiya Y, Hira Y, Kaneko A, Chiba
S, Suzuki T, Noguchi M and Watanabe T: Daikenchuto (TU-100)
ameliorates colon microvascular dysfunction via endogenous
adrenomedullin in Crohn's disease rat model. J Gastroenterol.
46:1187–1196. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kaneko A, Kono T, Miura N, Tsuchiya N and
Yamamoto M: Preventive effect of TU-100 on a Type-2 model of
colitis in mice: Possible involvement of enhancing adrenomedullin
in intestinal epithelial cells. Gastroenterol Res Pract.
2013:3840572013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nishikimi T, Shibasaki I, Iida H, Asakawa
H, Matsushita Y, Mori H, Mochizuki Y, Okamura Y, Horinaka S,
Kangawa K, et al: Molecular forms of adrenomedullin in pericardial
fluid and plasma in patients with ischaemic heart disease. Clin Sci
(Lond). 102:669–677. 2002. View Article : Google Scholar
|
|
23
|
Myren J, Bouchier IA, Watkinson G, Softley
A, Clamp SE and de Dombal FT: The O.M.G.E. multinational
inflammatory bowel disease survey 1976–1982. A further report on
2,657 cases. Scand J Gastroenterol Suppl. 95:1–27. 1984.
|
|
24
|
Kono T, Kaneko A, Omiya Y, Ohbuchi K, Ohno
N and Yamamoto M: Epithelial transient receptor potential ankyrin 1
(TRPA1)-dependent adrenomedullin upregulates blood flow in rat
small intestine. Am J Physiol Gastrointest Liver Physiol.
304:G428–G436. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nishikimi T, Matsuoka H, Shimada K, Matsuo
H and Kangawa K: Production and clearance sites of two molecular
forms of adrenomedullin in human plasma. Am J Hypertens.
13:1032–1034. 2000. View Article : Google Scholar : PubMed/NCBI
|
